Home' Australian Pharmacist : Australian Pharmacist May 2012 Contents 354 Australian Pharmacist May 2012 I ©Pharmaceutical Society of Australia Ltd.
By Dr Janette Randall, Chair of the NPS
On behalf of the
NPS Board and sta ,
and the National
committee, I am
to welcoming you
all to the National
Medicines Symposium (NMS) in Sydney
Held every two years, NMS is unique in
shining a spotlight on the work that is
being done both around Australia and
internationally to support the quality
use of medicines, and is the pre-eminent
event in this area.
This year's theme is 'building a
medicinewise community', and will
explore the challenges we face and the
opportunities available to make this
Attracting a broad range of delegates,
NMS provides an ideal opportunity to
hear not only of excellent work in the
medicines area, but also to network
with key policy makers and industry
peers. Both the plenary and small group
sessions are oriented towards improving
the experience of consumers in our
health system, and provide much food for
thought as we all plan and implement our
own programs of work.
The program features many home grown
leaders and experts in the elds of
medicines, ehealth and systems reform as
well as key international speakers in these
areas. Sessions on the program already
creating a buzz include a discussion
around the value expected from the
Personally Controlled Electronic Health
Record and a workshop on understanding
and meeting the needs of consumers
in the community pharmacy setting
and how innovations in practice are
contributing to this.
We have received a record number
of abstracts which are of a very high
quality, meaning we have added extra
oral presentation sessions to the agenda.
For the rst time this year, posters will
also be available in a digital format as well
as via the conference app and on location
using digital poster boards.
Entries for the inaugural National
MedicineWise Awards have also been
of a very high standard. These awards
acknowledge at the highest level
e orts by individuals, groups and
organisations to improve medicines
use and patient outcomes and we look
forward to congratulating the winners
of these awards for excellence at the
Each year we receive very positive
feedback about NMS, particularly around
how the event provides the opportunity
to look at what has been happening in
the medicines space, where we are going,
and for people to network and debate
with their peers.
I am always energised by the goodwill
and enthusiasm that surrounds NMS
-- the central focus of consumers, the
collaborative approach of the many
medicines partners, and the supportive
policy environment are key contributors
to this outcome.
NMS promises to showcase the depth
and breadth of the work currently
underway to improve medicines use.
I encourage you to join us this year to
learn and contribute, and to lend your
e orts to building a medicinewise
The 2012 National Medicines Symposium
(NMS) will be held 24--25 May at the
Sydney Convention & Exhibition Centre.
For more information visit: www.nps.org.
New teaching facility
The Faculty of Pharmacy and
Pharmaceutical Sciences, Monash
University o cially launched an innovative
teaching facility -- the Professional Practice
Suite (PPS), last month.
The $1.8 million education and
professional development facility is the
latest of a range of space, technology and
curriculum initiatives implemented by the
faculty. The Victorian College of Pharmacy
Foundation funded the PPS' development
with a number of major industry partners,
alumni and other supporters. The PPS
can accommodate up to 80 students and
o ers a combination of contemporary
and purpose-designed teaching spaces,
computer enabled tutorial spaces utilising
custom-designed software applications
such as MyDispense, consulting rooms
with video recording capability, and social
Professor Bill Charman, Dean of the
faculty said, 'we need to educate our
graduates for today's high level of
practice, but especially to lead change
and establish tomorrow's future
practices. Our solution, developed by
faculty sta , was the development of the
Professional Practice Suite. It is a unique
design that will facilitate the teaching of
contemporary dispensing, primary care
and patient communication skills in a
'hands on' manner.'
The Quality Pharmacy Consortium,
comprised of Quality Pharmacy
Group, Rose Health, Willach, Abbott
Pharmaceuticals, Ascent Pharmaceuticals
and Rajan Pharmacies, was the rst
pharmaceutical industry partner to make
a lead gift to the project followed by
pharmaceutical wholesaler API.
Charles Khallouf, Convenor of the
Quality Pharmacy Consortium said,
'historically the role of the pharmacists
has been primarily the dispensing of
prescriptions with some advice services.
There is now the opportunity to expand
the pharmacists' role to do much more.
The PPS will facilitate the development
of a new breed of pharmacist trained to
take responsibility for the overall health
condition and deliver improved outcomes
for their patients'.
Links Archive Australian Pharmacist June 2012 Australian Pharmacist April 2012 Navigation Previous Page Next Page